Prevalence of infectious agents in patients with systemic sclerosis: defining the control group

Basit Öğe Kaydı
dc.contributor.authorBilgin, Huseyin
dc.contributor.authorKOCABAŞ, Hilal
dc.contributor.authorKesli, Recep
dc.date.accessioned2025-10-24T18:04:41Z
dc.date.available2025-10-24T18:04:41Z
dc.date.issued2016
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstract-
dc.identifier.endpage1612
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.issue5
dc.identifier.startpage1612
dc.identifier.trdizinid252461
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/252461
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3011
dc.identifier.volume46
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofTurkish Journal of Medical Sciences
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzTR-Dizin_20251023
dc.subjectGenel ve Dahili Tıp
dc.subjectOnkoloji
dc.titlePrevalence of infectious agents in patients with systemic sclerosis: defining the control group
dc.typeEditorial

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu